Tag: Bluegrass Vascular
Bluegrass Vascular announces Journal of Vascular Surgery paper reporting use of...
Bluegrass Vascular Technologies recently announced the publication of a paper featured on the cover of the June 2022 issue of the Journal of Vascular Surgery (JVS). The paper...
Bluegrass Vascular announces Medicare decision to assign New Technology Ambulatory Payment...
Bluegrass Vascular Technologies (Bluegrass Vascular) announced today that the Centers for Medicare & Medicaid Services (CMS) has finalised a new Healthcare Common Procedure Coding...
SAVE registry evidences safety of Surfacer system
The Surfacer Inside-Out access catheter system device (Bluegrass Vascular) is safe and effective for patients with thoracic central venous obstruction requiring central venous access....
Surfacer system IDE study results published in Journal of Vascular Access
Bluegrass Vascular Technologies has announced the publication of the results of its prospective, multicentre SAVE-US (Surfacer system to facilitate access in venous occlusions—United States)...
Bluegrass Vascular Technologies announces first US commercial cases with the Surfacer...
Bluegrass Vascular Technologies has announced that the first US commercial cases using the Surfacer Inside-Out access catheter system were completed at Santa Clara Valley...
FDA grants de novo clearance to Bluegrass Vascular for Surfacer system
Bluegrass Vascular Technologies (Bluegrass Vascular) announced today that the US Food and Drug Administration (FDA) has granted a de novo classification order for its...
Positive Surfacer Inside-Out multicentre study results published
Bluegrass Vascular Technologies has announced the publication of positive results associated with a clinical study involving the use of the Surfacer Inside-Out access catheter...
Bluegrass Vascular announce publication of positive clinical results Surfacer system published
Bluegrass Vascular Technologies (Bluegrass Vascular) has announced the publication of positive results associated with the clinical use of the Surfacer Inside-Out access catheter system...
SAVE-US pivotal trial completes enrolment and has positive clinical results
The SAVE-US (Surfacer system to facilitate access in venous occlusions—United States) pivotal trial has completed enrollment. The SAVE-US trial is evaluating the safety and...
Retrospective study finds 97% success rate with Surfacer Inside-Out access catheter
The Surfacer Inside-Out Access Catheter System (Bluegrass Vascular) has demonstrated positive commercial use, consistently achieving central venous access in patients with upper body occlusions....
Bluegrass Vascular’s SAVE-US catheter access device trial begins enrolment
Bluegrass Vascular Technologies has announced the enrolment of its first patients in the SAVE-US (Surfacer System to Facilitate Access in Venous Occlusions–United States) pivotal trial.
The SAVE-US trial is...
First patients enrolled in Bluegrass Vascular post-market SAVE study
Bluegrass Vascular Technologies has enrolled over one third of its patients in the company's post-market SAVE (Surfacer System to Facilitate Access in Venous Occlusions)...
Bluegrass Vascular announces strategic relationship with Merit Medical
Bluegrass Vascular Technologies is entering into a strategic relationship with Merit Medical Systems. The agreement will streamline European distribution of the recently CE mark-approved Surfacer Inside-Out...
